MARKWALDER JAY A,SEITZ STEVEN P,BALOG JAMES AARON,HUANG AUDRIS,WILLIAMS DAVID K,CHEN LIBING,MANDAL SUNIL KUMAR,SRIVASTAVA SHEFALI
申请号：
IN201617009847
公开号：
IN201617009847A
申请日:
2016.03.21
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO) pharmaceutical compositions containing said compounds and methods of treating proliferative disorders such as cancer viral infections and/or autoimmune diseases utilizing the compounds of the invention.
